Next Article in Journal
Chronic Glaucoma Using Biodegradable Microspheres to Induce Intraocular Pressure Elevation. Six-Month Follow-Up
Next Article in Special Issue
Diagnostic Accuracy of Dehydroepiandrosterone Sulfate and Corticotropin in Autonomous Cortisol Secretion
Previous Article in Journal
Altered Calcium Influx Pathways in Cancer-Associated Fibroblasts
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 9
Issue 6
10.3390/biomedicines9060681
Review Report
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article
Peer-Review Record

Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α

Biomedicines 2021, 9(6), 681; https://doi.org/10.3390/biomedicines9060681
by Elisa Rossini 1,†, Edoardo Giacopuzzi 2,3,†, Fabrizio Gangemi 4,†, Mariangela Tamburello 1, Deborah Cosentini 5, Andrea Abate 1, Marta Laganà 5, Alfredo Berruti 5, Salvatore Grisanti 5,‡ and Sandra Sigala 1,*,‡
Reviewer 1:
Peter Igaz
Reviewer 2: Anonymous
Biomedicines 2021, 9(6), 681; https://doi.org/10.3390/biomedicines9060681
Submission received: 29 May 2021 / Revised: 12 June 2021 / Accepted: 14 June 2021 / Published: 16 June 2021
(This article belongs to the Special Issue Pathogenesis and Treatment of Adrenal Tumors)

Round 1

Reviewer 1 Report

This is a very interesting manuscript on the mitotane and its interaction/action on the estrogen receptor. The manuscript raises an important clinical problem and approaches it both via structural chemical and in vitro pharmacological cell line experiments. The manuscript is well-written, easy to follow, and the applied methodology, results, discussion and the conclusions are clear. The results have clear clinical relevance, as they seem to explain clinical findings, and can form the basis of further translational studies that could eventually lead to better compounds in the combat against adrenocortical cancer.

Author Response

We thank very much the Reviewer for his/her comments and we are glad he/she appreciated our work

Reviewer 2 Report

Only editorial revisions will be needed.

  1. page 1, line 3 of ABSTRACT, page 2, line 18: Estrogen Receptor-α should be estrogen receptor-α
  2. Page 2, line 16: 17β-estradiol should be 17β-estradiol (E2), after this, E2 should be used instead of 17β-estradiol in the text and figure legends
  3. page 2, line 22: ER-α and Estrogen Receptor-β (ER-β) should be ER-α and ER-β
  4. page 4, line 10: ThermoFisher scientific should be ThermoFisher Scientific
  5. page 4, line 15: add a space after 24
  6. page 4, line 17: hour should be h
  7. page 4, line 23: 3-(4,5-Dimethyl... should be 3-(4,5-dimethyl...
  8. page 4, line 36: hour should be h
  9. page 4, line 43: add a space after 6
  10. page 4, line 48: hours should be h
  11. page 5, line 10: hour should be h
  12. page 8, line 18: add a space after 24
  13. page 9, line 2: hour should be h
  14. page 9, line 7: add a space after 24
  15. page 9, line 11: hours should be h
  16. References no. 3, 5, 7, 36, 40, 43: titles should be small capital

Author Response

We thank very much the Reviewer for his/her comments.

We corrected the Ms in each point he/she suggested.

Further, I added the note: M.T. and A.A. are enrolled in the PhD Program on Precision Medicine, University of Brescia

Back to TopTop